Older Patients: Clinical Trials

3 trials for Older Patients, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Older Patients: new trials by email Literature Review of Older Patients trials Research Report on Older Patients

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT
Venetoclax (VEN), Decitabine (DAC), Busulfan (Bu) - Older Patients, Myeloid Malignancies
Phase 2 / Phase 3Not yet recruitingNanfang Hospital, Southern Medical University1602025-07-152025-07-04
DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
Doublet Chemotherapy, Standard Dose (100%), Doublet Chemotherapy, Dose-reduced (75%), Monotherapy, Standard Dose (100%) - Older Patients, Colorectal Cancer
Phase 3RecruitingLeiden University Medical Center5872024-07-012024-10-16
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
CDK 4/6 inhibitors, Endocrine therapy - Metastatic Breast Cancer, Advanced Breast Cancer
Phase 3RecruitingRegion Örebro County4952024-04-012024-11-19

Narrower conditions

Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Breast Diseases (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Rectal Diseases (1)  ·  Skin Diseases (1)

Interventions

Busulfan (1)  ·  Decitabine (1)  ·  Influenza Vaccines (1)  ·  fludarabine (1)  ·  venetoclax (1)

Sponsors

Leiden University Medical Center (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  Region Örebro County (1)

Countries

Finland (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Antonios Valachis, Assoc Prof (1)  ·  Johanneke Portielje, Professor (1)  ·  Joosje Baltussen, MD (1)  ·  Qifa Liu (1)

Results publications

PMID 39142680, PMID 39431459

NIH funding

2023 (1)